![Mathai Mammen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathai Mammen
Directeur Général chez
PARABILIS MEDICINES, INC.
Fortune : 610 356 $ au 31/10/2026
Profil
Dr. Mathai Mammen is an Independent Director at Sandoz Group AG, a Chairman, President & Chief Executive Officer at Parabilis Medicines, Inc., an Advisor at Foresite Capital Management LLC and a Senior Advisor at General Atlantic LP.
He is on the Board of Directors at Sandoz Group AG, Kelonia Therapeutics, Inc. and MIT Jameel Clinic.
Dr. Mammen was previously employed as an Independent Director by 10X Genomics, Inc., an EVP-Pharmaceuticals, Research & Development by Johnson & Johnson, a Global Head-Research & Development by Janssen Research & Development LLC, a Senior Vice President by Merck & Co., Inc., a Senior Vice President by Merck Research Laboratories Massachusetts LLC, a Senior Vice President-Research & Development by Theravance Biopharma, Inc., a Senior VP-Research & Early Clinical Development by Theravance, Inc., and a Vice President by American Society for Microbiology.
He received his undergraduate degree from Dalhousie University, a doctorate degree from Harvard Medical School, a doctorate degree from Harvard University and a doctorate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 6 098 ( 0 % ) | 610 356 $ | 31/10/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
Dernières actualités sur Mathai Mammen
Postes actifs de Mathai Mammen
| Sociétés | Poste | Début |
|---|---|---|
| PARABILIS MEDICINES, INC. | Directeur Général | 30/06/2023 |
| SANDOZ GROUP AG | Directeur/Membre du Conseil | 30/04/2024 |
MIT Jameel Clinic | Directeur/Membre du Conseil | - |
Kelonia Therapeutics, Inc.
 Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops pipeline of genetic medicines | Directeur/Membre du Conseil | - |
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Consultant / Advisor | 01/01/2019 |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic invests in both public and private companies located across the globe. The firm focuses on climate, consumer, financial services, healthcare, life sciences, and technology sectors. It participates in late and growth stage transactions. The firm acquires minority interest. | Consultant / Advisor | - |
Anciens postes connus de Mathai Mammen
| Sociétés | Poste | Fin |
|---|---|---|
| 10X GENOMICS, INC. | Directeur/Membre du Conseil | 24/10/2024 |
| JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | 08/08/2022 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | 01/01/2022 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mathai Mammen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
General Atlantic LLC
General Atlantic LLC Investment ManagersFinance General Atlantic invests in both public and private companies located across the globe. The firm focuses on climate, consumer, financial services, healthcare, life sciences, and technology sectors. It participates in late and growth stage transactions. The firm acquires minority interest. | Finance |
10X Genomics, Inc.
 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services Provides professional education services | Commercial Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Finance |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs to target disease causing proteins | Health Technology |
MIT Jameel Clinic | |
Kelonia Therapeutics, Inc.
Kelonia Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops pipeline of genetic medicines | Health Technology |
Sandoz Group AG
 Sandoz Group AG Pharmaceuticals: MajorHealth Technology Manufactures medicines and biosimilars | Health Technology |
